GlassScriptPhysician profile
David T Shin
NPI 1225523293
$25,587.88
in general payments reported to CMS, 2019-2025
11 companies · $11K in 2025
The $11K reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $486 · 2022: $2,436 · 2023: $1,267 · 2024: $10K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $6,901 · Food and Beverage: $5,132 · Education: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $6,900.87 |
| Food and Beverage | $5,131.64 |
| Education | $632.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13,879.28 | 2023-2025 | Advisa Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Affera Mapping System |
| Abbott Laboratories | $7,205.36 | 2021-2025 | Ensite, Ensite Precision, Cardiomems |
| Boston Scientific Corporation | $3,908.04 | 2021-2025 | Versacross Access Solution, Watchman Access System, Farapulse |
| Astellas Pharma US INC | $288.99 | 2021-2022 | |
| Amgen INC. | $135.29 | 2024 | Repatha |
| Impulse Dynamics (USA) INC. | $56.64 | 2023 | Optimizer |
| Pfizer INC. | $32.07 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.44 | 2024 | Lifevest |
| Abiomed | $20.98 | 2024 | Impella |
| Edwards Lifesciences Corporation | $18.46 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Livanova USA, INC. | $17.33 | 2023 | Protekduo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.